We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,964 results
  1. Effect of Unmetabolized Folic Acid on Immunoinflammatory Markers in Sickle Cell Disease Patients Taking Folic Acid Supplementation

    Folic acid (FA) supplementation in sickle cell disease (SCD) patients lead to accumulation of unmetabolized folic acid (UMFA) which might influence...

    Diksha Chandrakar, Suprava Patel, ... Dablu L. Gupta in Indian Journal of Clinical Biochemistry
    Article 20 March 2024
  2. Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease

    Sickle cell disease (SCD) is a lifelong blood disorder affecting approximately 100,000 people in the United States and is one of the most common...

    Guillaume Feugray, Maximilien Grall, ... Paul Billoir in Lipids in Health and Disease
    Article Open access 16 May 2024
  3. Anti-inflammatory cytokines in sickle cell disease

    Sickle cell disease (SCD) is a well-studied monogenetic disease with an established chronic inflammatory component . The paradigm shift towards...

    Adekunle E. Alagbe, Igor F. Domingos, ... Magnun N. N. Santos in Molecular Biology Reports
    Article 09 January 2022
  4. ATR1 Angiotensin II Receptor Reduces Hemoglobin S Polymerization, Phosphatidylserine Exposure, and Increases Deformability of Sickle Cell Disease Erythrocytes

    Angiotensin II (Ang II) regulates blood volume and stimulates erythropoiesis through AT1 (ATR1) and AT2 (ATR2) receptors, found in multiple tissues,...

    Camila Cristina Guimarães-Nobre, Evelyn Mendonça-Reis, ... Clemilson Berto-Junior in Cell Biochemistry and Biophysics
    Article 29 September 2022
  5. Atomic force microscopy reveals involvement of the cell envelope in biomechanical properties of sickle erythrocytes

    Background

    Intracellular hemoglobin polymerization has been supposed to be the major determinant for the elevated rigidity/stiffness of sickle...

    Kun Wang, Zhiqiang Li, ... Yong Chen in BMC Biology
    Article Open access 13 February 2023
  6. Redefining the Reference Interval and Cut-Off Values of the Hematological and Biochemical Parameters and Deriving a Sensitive Predictive Marker for Crisis Events in Sickle Cell Disease

    The heterogeneity in clinical presentations in sickle cell disease (SCD) alters between crisis and steady state phases. Considering the...

    Suprava Patel, Diksha Chandrakar, ... Ashish Gupta in Indian Journal of Clinical Biochemistry
    Article 24 October 2023
  7. Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell disease, on behalf of the IHCC consortium

    Background

    Previous study has shown that dyslipidemia is common in patients with Sickle cell disease (SCD) and is associated with more serious SCD...

    Hui-Qi Qu, Joseph Glessner, ... Hakon Hakonarson in Metabolomics
    Article Open access 02 December 2022
  8. Hematologic Disease

    Iron deficiency does not cause proliferative change or skull “porosityPorosity.” Marrow hyperplasiaHyperplasia is elicited by blood loss or...
    Chapter 2023
  9. Sickle cell trait enhances malaria transmission

    Evans Aduhene, Regina Joice Cordy in Nature Microbiology
    Article 21 August 2023
  10. Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania

    Background

    Sickle cell disease (SCD) is an important cause of under-five mortality. Tanzania is the 5th country in the world with the highest births...

    Heavenlight Christopher, Adam Burns, ... Siana Nkya in BMC Genomics
    Article Open access 16 December 2021
  11. Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia

    Background

    Sickle Cell Anemia (SCA) is a genetic disease caused by the c.20 A > T mutation in HBB gene, generally characterized by sickle...

    Isabel Germano, Brígida Santos, ... Paula Faustino in Molecular Biology Reports
    Article 12 September 2022
  12. Polymorphisms and gene expression of metalloproteinases and their inhibitors associated with cerebral ischemic stroke in young patients with sickle cell anemia

    Background

    Sickle cell anemia (SCA) is a genetic disease with great clinical heterogeneity and few viable strategies for treatment; hydroxyurea (HU)...

    Ó. do Kleyton Palmeira, Ana Karla da Silva Freire, ... Luydson Richardson Silva Vasconcelos in Molecular Biology Reports
    Article 01 February 2023
  13. Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease

    The aim of the study is to evaluate the stability and longevity of the paper-based screening test for the sickle cell disease in relation to...

    Ravindra Kumar, Sweta Mishra, ... Rajasubramaniam Shanmugam in Indian Journal of Clinical Biochemistry
    Article 08 February 2021
  14. Prediction of Hydroxyurea Effect on Sickle Cell Anemia Patients Using Machine Learning Method

    The objective of this paper is to predict the effect of hydroxyurea of individuals suffering from Sickle Cell Disease (SCD) using predictive machine...
    Bikesh Kumar Singh, Apoorva Ojha, ... Pradeep Kumar Patra in Advances in Biomedical Engineering and Technology
    Conference paper 2021
  15. Sickle cell gene therapies approach watershed

    Cormac Sheridan in Nature Biotechnology
    Article 09 November 2021
  16. Co-Inheritance of alpha-thalassemia and sickle cell disease in a cohort of Angolan pediatric patients

    The aim of this study was to explore the association between alpha-thalassemia, fetal hemoglobin, hematological indices, and clinical adverse events...

    Brígida Santos, Mariana Delgadinho, ... Miguel Brito in Molecular Biology Reports
    Article 06 July 2020
Did you find what you were looking for? Share feedback.